Circulating tumor cells in colorectal cancer:: correlation with clinical and pathological variables

被引:179
作者
Sastre, J. [1 ]
Maestro, M. L. [2 ]
Puente, J. [1 ]
Veganzones, S. [2 ]
Alfonso, R. [1 ]
Rafael, S. [2 ]
Garcia-Saenz, J. A. [1 ]
Vidaurreta, M. [2 ]
Martin, M. [1 ]
Arroyo, M. [2 ]
Sanz-Casla, M. T. [2 ]
Diaz-Rubio, E. [1 ]
机构
[1] Hosp Clin San Carlos Madrid, Med Oncol Serv, Madrid 28040, Spain
[2] Hosp Clin San Carlos Madrid, Dept Cent Lab, Madrid, Spain
关键词
colorectal cancer; circulating tumor cells; clincal variables;
D O I
10.1093/annonc/mdm583
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The CellSearch System is a technique to detect circulating tumor cells (CTCs) in patients with cancer. Few data have been published concerning the role of CTCs detection by this method in colorectal cancer. The aim of this study was to correlate the presence of CTCs with the commonest clinical and morphological variables. Patients and methods: Blood samples were collected from 97 patients and 30 healthy volunteers. Quantification of CTCs in 7.5 ml of blood was carried out with the CellSearch System. The results were expressed as number of CTCs/7.5 ml and the cut-off of >= 2 CTCs/7.5 ml was chosen to define the test as positive. Results: Positive CTCs were detected in 34 of 94 patients (36.2%). Correlation was not found among positive CTCs and location of primary tumor, increased carcinoembryonic antigen level, increased lactate dehydrogenase level or grade of differentiation. Only stage correlated with positive CTCs (20.7% in stage II, 24.1% in stage III and 60.7% in stage IV, P = 0.005). Conclusions: CTCs detection by CellSearch is a highly reproducible method that correlates with stage but not with other clinical and morphological variables in patients with colorectal cancer. Colon cancer tumor cells are detectable in all stages. Further studies are warranted.
引用
收藏
页码:935 / 938
页数:4
相关论文
共 15 条
[1]   Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].
Allard, WJ ;
Matera, J ;
Miller, MC ;
Repollet, M ;
Connelly, MC ;
Rao, C ;
Tibbe, AGJ ;
Uhr, JW ;
Terstappen, LWMM .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904
[2]   Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma [J].
Allen-Mersh, T. G. ;
McCullough, T. K. ;
Patel, H. ;
Wharton, R. Q. ;
Glover, C. ;
Jonas, S. K. .
BRITISH JOURNAL OF SURGERY, 2007, 94 (01) :96-105
[3]   Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer [J].
Bessa, X ;
Elizalde, JI ;
Boix, L ;
Piñol, V ;
Lacy, AM ;
Saló, J ;
Piqué, JM ;
Castells, A .
GASTROENTEROLOGY, 2001, 120 (05) :1084-1092
[4]  
COHEN SJ, 2006, P AM SOC CLIN ONCOL, V24
[5]   Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer [J].
Cohen, Steven J. ;
Alpaugh, R. Katherine ;
Gross, Steve ;
O'Hara, Shawn M. ;
Smirnov, Denis A. ;
Ferstappen, Leon W. M. M. ;
Allard, W. Jeffrey ;
Bilbee, Maryann ;
Cheng, Jonathan D. ;
Hoffman, John P. ;
Lewis, Nancy L. ;
Pellegrino, Ann ;
Rogatko, Andre ;
Sigurdson, Elin ;
Wang, Hao ;
Watson, James C. ;
Weiner, Louis M. ;
Meropol, Neal J. .
CLINICAL COLORECTAL CANCER, 2006, 6 (02) :125-132
[6]   Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer [J].
Cristofanilli, M ;
Hayes, DF ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Reuben, JM ;
Doyle, GV ;
Matera, J ;
Allard, WJ ;
Miller, MC ;
Fritsche, HA ;
Hortobagyi, GN ;
Terstappen, LWMM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1420-1430
[7]   Long-term prognostic value of detection of circulating colorectal cancer cells using CGM2 reverse transcriptase-polymerase chain reaction assay [J].
Douard, R ;
Wind, P ;
Sales, JP ;
Landi, B ;
Berger, A ;
Benichou, J ;
Gayral, F ;
Loric, S ;
Cugnenc, PH .
SURGERY, 2006, 139 (04) :556-562
[8]   Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival [J].
Hayes, Daniel F. ;
Cristofanilli, Massimo ;
Budd, G. Thomas ;
Ellis, Matthew J. ;
Stopeck, Alison ;
Miller, M. Craig ;
Matera, Jeri ;
Allard, W. Jeffrey ;
Doyle, Gerald V. ;
Terstappen, Leon W. W. M. .
CLINICAL CANCER RESEARCH, 2006, 12 (14) :4218-4224
[9]   Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer:: results of a multivariate analysis of 3825 patients [J].
Köhne, CH ;
Cunningham, D ;
Di Costanzo, F ;
Glimelius, B ;
Blijham, G ;
Aranda, E ;
Scheithauer, W ;
Rougier, P ;
Palmer, M ;
Wils, J ;
Baron, B ;
Pignatti, F ;
Schöffski, P ;
Micheel, S ;
Hecker, H .
ANNALS OF ONCOLOGY, 2002, 13 (02) :308-317
[10]  
MEROPOL NJ, 2007, P AN M AM SOC CLIN, V25, pS166